Technology collaboration – TODE20150318001 OFFER
Scientists at a German university developed compounds to treat neoplastic diseases or proliferative disorders, such as chronic lymphocytic leukemia (CLL). In tests on different CLL populations the compounds show a high selectivity towards neoplastic cells. The activity was proven in a xenograft model of CLL. Licensees from the pharmaceutical industry are sought.
Powered by WPeMatico
Technology collaboration – TOIT20150303001 OFFER Una organización biomédica italiana formada por médicos y científicos en biomedicina, específicamente ginecólogos y biólogos, que trabajan […]
Technology collaboration – TOCZ20150326001 OFFER Un equipo de investigación de una universidad checa ha descubierto y evaluado inhibidores de caseína quinasa 1 […]
Technology collaboration – TOCZ20150325001 OFFER A Czech university offers a technology designed for rapid and efficient ‘in cell’ activity profiling of human […]
Technology collaboration – TORU20150507001 OFFER Small Russian innovative company is developing the surgical instrument of next generation that is two-wave laser system, […]
